AddLife AB (publ) (ALIF-B.ST)
SEK 189.0
(3.28%)
SEK 189.0
(3.28%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 9.68 Billion SEK | 6.62% |
| 2022 | 9.08 Billion SEK | 13.66% |
| 2021 | 7.99 Billion SEK | 51.57% |
| 2020 | 5.27 Billion SEK | 51.56% |
| 2019 | 3.47 Billion SEK | 40.21% |
| 2018 | 2.48 Billion SEK | 6.36% |
| 2017 | 2.33 Billion SEK | 20.38% |
| 2016 | 1.93 Billion SEK | 24.06% |
| 2015 | 1.56 Billion SEK | -9.3% |
| 2014 | 1.72 Billion SEK | 75.15% |
| 2013 | 983.5 Million SEK | 8.49% |
| 2012 | 906.5 Million SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 2.55 Billion SEK | -0.62% |
| 2024 Q3 | 2.34 Billion SEK | -8.22% |
| 2024 Q1 | 2.57 Billion SEK | 1.02% |
| 2023 Q1 | 2.45 Billion SEK | 5.63% |
| 2023 Q3 | 2.31 Billion SEK | -1.95% |
| 2023 Q2 | 2.36 Billion SEK | -3.74% |
| 2023 FY | 9.68 Billion SEK | 6.62% |
| 2023 Q4 | 2.54 Billion SEK | 9.7% |
| 2022 Q4 | 2.32 Billion SEK | 10.76% |
| 2022 Q2 | 2.07 Billion SEK | -19.39% |
| 2022 Q1 | 2.57 Billion SEK | 21.05% |
| 2022 FY | 9.08 Billion SEK | 13.66% |
| 2022 Q3 | 2.1 Billion SEK | 1.01% |
| 2021 Q4 | 2.13 Billion SEK | 15.17% |
| 2021 FY | 7.99 Billion SEK | 51.57% |
| 2021 Q1 | 1.73 Billion SEK | 0.27% |
| 2021 Q2 | 2.27 Billion SEK | 31.11% |
| 2021 Q3 | 1.85 Billion SEK | -18.72% |
| 2020 FY | 5.27 Billion SEK | 51.56% |
| 2020 Q4 | 1.73 Billion SEK | 39.51% |
| 2020 Q3 | 1.24 Billion SEK | -0.56% |
| 2020 Q2 | 1.24 Billion SEK | 18.52% |
| 2020 Q1 | 1.05 Billion SEK | 6.54% |
| 2019 Q4 | 988.4 Million SEK | 23.24% |
| 2019 Q1 | 845 Million SEK | 23.43% |
| 2019 Q3 | 802 Million SEK | -4.98% |
| 2019 Q2 | 844 Million SEK | -0.12% |
| 2019 FY | 3.47 Billion SEK | 40.21% |
| 2018 Q2 | 622 Million SEK | 4.19% |
| 2018 FY | 2.48 Billion SEK | 6.36% |
| 2018 Q4 | 684.6 Million SEK | 18.44% |
| 2018 Q3 | 578 Million SEK | -7.07% |
| 2018 Q1 | 597 Million SEK | -10.67% |
| 2017 Q2 | 572 Million SEK | -0.69% |
| 2017 FY | 2.33 Billion SEK | 20.38% |
| 2017 Q3 | 517 Million SEK | -9.62% |
| 2017 Q1 | 576 Million SEK | -5.81% |
| 2017 Q4 | 668.3 Million SEK | 29.26% |
| 2016 Q2 | 465 Million SEK | 67.45% |
| 2016 Q3 | 409.1 Million SEK | -12.02% |
| 2016 Q1 | 277.7 Million SEK | -41.18% |
| 2016 Q4 | 611.5 Million SEK | 49.47% |
| 2016 FY | 1.93 Billion SEK | 24.06% |
| 2015 FY | 1.56 Billion SEK | -9.3% |
| 2015 Q3 | 370.5 Million SEK | 38.71% |
| 2015 Q4 | 472.1 Million SEK | 27.42% |
| 2015 Q1 | 950.5 Million SEK | 214.84% |
| 2015 Q2 | 267.1 Million SEK | -71.9% |
| 2014 FY | 1.72 Billion SEK | 75.15% |
| 2014 Q4 | 301.9 Million SEK | 0.0% |
| 2013 FY | 983.5 Million SEK | 8.49% |
| 2012 FY | 906.5 Million SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Biotage AB (publ) | 1.86 Billion SEK | -420.14% |
| Bonesupport Holding AB (publ) | 591.07 Million SEK | -1538.534% |
| Doxa AB (publ) | 9.9 Million SEK | -97728.283% |
| Elekta AB (publ) | 18.11 Billion SEK | 46.548% |
| iZafe Group AB (publ) | 1.82 Million SEK | -531458.727% |
| Ortivus AB (publ) | 84.08 Million SEK | -11418.655% |
| Ortivus AB (publ) | 84.08 Million SEK | -11418.655% |
| Q-linea AB (publ) | 4.44 Million SEK | -218030.631% |
| S2Medical AB (publ) | 6.97 Million SEK | -138825.826% |
| Synsam AB (publ) | 5.9 Billion SEK | -64.014% |